Price Alert

AstraZeneca (AZNCF)

OTC: AZNCF · Real-Time Price · USD

162.00

1.86 (1.16%)

At close: Sep 11, 2025, 3:47 PM

160.14

-1.15%

After-hours: Sep 09, 2025, 08:00 PM EDT

AstraZeneca Statistics

Share Statistics

AstraZeneca has 1.55B shares outstanding. The number of shares has increased by 0.02% in one year.

Shares Outstanding	1.55B
Shares Change (YoY)	0.02%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	1.47B
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 178.99K, so 0.01% of the outstanding shares have been sold short.

Short Interest	178.99K
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	13.92

Valuation Ratios

The PE ratio is 28.64 and the forward PE ratio is 15.54. AstraZeneca's PEG ratio is 1.57.

PE Ratio	28.64
Forward PE	15.54
PS Ratio	3.73
Forward PS	4
PB Ratio	4.94
P/FCF Ratio	27.7
PEG Ratio	1.57

Financial Ratio History

Enterprise Valuation

AstraZeneca has an Enterprise Value (EV) of 226.13B.

EV / Sales	4.18
EV / EBITDA	14.65
EV / EBIT	19.06
EV / FCF	31.08

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.74.

Current Ratio	0.93
Quick Ratio	0.74
Debt / Equity	0.74
Debt / EBITDA	1.95
Debt / FCF	4.14
Interest Coverage	7.34

Financial Efficiency

Return on Equity is 17.25% and Return on Invested Capital is 10.3%.

Return on Equity	17.25%
Return on Assets	6.76%
Return on Invested Capital	10.3%
Revenue Per Employee	$573.41K
Profits Per Employee	$74.6K
Employee Count	94,300
Asset Turnover	0.52
Inventory Turnover	1.93

Taxes

Income Tax	1.65B
Effective Tax Rate	18.99%

Stock Price Statistics

The stock price has increased by -0.06% in the last 52 weeks. The beta is 0.17, so AstraZeneca's price volatility has been higher than the market average.

Beta	0.17
52-Week Price Change	-0.06%
50-Day Moving Average	150.75
200-Day Moving Average	142.86
Relative Strength Index (RSI)	55.54
Average Volume (20 Days)	3,312

Income Statement

In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 4.54.

Revenue	54.07B
Gross Profit	43.87B
Operating Income	10B
Net Income	7.04B
EBITDA	15.44B
EBIT	10.37B
Earnings Per Share (EPS)	4.54

Full Income Statement

Balance Sheet

The company has 5.49B in cash and 30.11B in debt, giving a net cash position of -24.63B.

Cash & Cash Equivalents	5.49B
Total Debt	30.11B
Net Cash	-24.63B
Retained Earnings	3.16B
Total Assets	112.42B
Working Capital	-4.6B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.86B and capital expenditures -4.59B, giving a free cash flow of 7.28B.

Operating Cash Flow	11.86B
Capital Expenditures	-4.59B
Free Cash Flow	7.28B
FCF Per Share	4.69

Full Cash Flow Statement

Margins

Gross margin is 81.12%, with operating and profit margins of 18.5% and 13.01%.

Gross Margin	81.12%
Operating Margin	18.5%
Pretax Margin	16.07%
Profit Margin	13.01%
EBITDA Margin	28.55%
EBIT Margin	18.5%
FCF Margin	13.45%

Dividends & Yields

AZNCF pays an annual dividend of $4.12, which amounts to a dividend yield of 2.21%.

Dividend Per Share	$4.12
Dividend Yield	2.21%
Dividend Growth (YoY)	7.31%
Payout Ratio	77.68%
Earnings Yield	3.49%
FCF Yield	3.61%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for AZNCF.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$53.53
Lynch Upside	-66.57%
Graham Number	51.84
Graham Upside	-67.63%

Scores

Altman Z-Score	3.15
Piotroski F-Score	7